NCT05163574: Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy
- State
- State not given
- Phase
- No phase
- People
- 40 planned
- Started
- 5 Feb 2022
- Primary completion
- 31 Dec 2023
- Arms
- High dose
- Results
- None posted
- 20 Dec 2021: Trial registered
- 5 Feb 2022: Trial started